Pharmaceuticals
-
Anti-Ebola drug and antibody show promise
The anti-Ebola drug remdesivir has shown major promise in a global clinical trial involved Covid-19 patients, it was announced last night. Read more
-
Hope for non-chemo prostate cancer drug
The breast and ovarian cancer drug olaparib may also be effective against prostate cancer. Read more
-
Hope for Covid-19 inflammation therapy
Scientists are working on a new nanoparticle treatment for septic shock and uncontrolled inflammation that might help Covid-19 care. Read more
-
Action of key tuberculosis drug identified
British scientists say they have found how a key drug can kill the tuberculosis bacterium, potentially paving the way for the development of new therapies. Read more
-
Is a peptide the answer to antibiotic resistance?
A peptide could be the answer to halting antibiotic resistance, according to a Swedish study. Read more
-
Covid-19 antiviral drug trial unsuccessful – but vaccine trials launched
British doctors are to begin clinical trials of a vaccine against Covid-19 infection tomorrow – as trials of antiviral medicines continued to prove disappointing. Read more
-
Decoy protein could halt Covid-19
Scientists are developing decoy proteins that bind and trap the coronavirus to stop it infecting cells, it has been announced. Read more
-
German and UK parents most anti-vaccinations
One in 30 parents in Germany and the UK are anti-vaccinations regardless of which disease they are for, according to a new study. Read more
-
Transfer of drug-resistant microbes between pets and humans ‘minimal’
Pets are not a major source of transmission of drug-resistant microbes to the owners, according to a study prepared for a cancelled European conference. Read more
-
Could overactive immune cells contribute to Covid-19 deaths?
Medical researchers from across the globe are investigating if overactive immune cells that produce Neutrophil Extracellular Traps (NETs) cause the most severe Covid-19 cases. Read more
